Chromosome fragility and predisposition to childhood malignancies.
In order to clarify the possible connection between autosomal folate sensitive Fragile Sites (FS) and genetic susceptibility to haemopoetic disease in children we investigated the frequency and distribution of FS in the Peripheral Blood Lymphocytes (PBL) of 56 children with newly diagnosed and untreated haematologic malignancies and their parents. The incidence was compared with that of 146 normal controls (children and adults). In all patients the Bone Marrow (BM) karyotype was also determined. Heritable FS were detected in 49 patients (87.5%). 20 children had more than one FS and in all cases it was inherited from one of their parents, although there was a significant excess of transmitting mothers. 19 different FS were identified: 14 common, 4 rare and one, 22q11, which has not been previously reported, but it is considered as important as it coincides with the cancer breakpoint resulting in the formation of the Philadelphia (Ph) chromosome. The frequency of FS in the PBL of the patients was significantly higher than in the controls and this increase was independent of any abnormality detected in the malignant cells of the BM. However, patients with an abnormal BM karyotype displayed increased frequency of FS induction as compared to patients with a normal karyotype. In three cases the heritable FS was found to be at or near the breakpoints of the chromosomal rearrangements detected in the malignant cells. The findings are discussed with regard to cancer specific breakpoints, oncogene loci and sites where viral DNA can be inserted to the genome. The results of this study suggest that autosomal folate sensitive FS may increase the risk for haematologic malignancies through a complex mechanism which remains to be clarified.
Kolialexi
A
A
1st Department of Pediatrics, Athens University, Aghia Sophia Children's Hospital, Greece.
Mavrou
A
A
Tsenghi
C
C
Tsangaris
G T
GT
Dafermou
E
E
Tzortzatou
F
F
Polychronopoulou
S
S
Haidas
S
S
Metaxotou
C
C
D000328:Adult; D002648:Child; D002675:Child, Preschool; D043283:Chromosome Fragile Sites; D002873:Chromosome Fragility; D002874:Chromosome Mapping; D005260:Female; D020022:Genetic Predisposition to Disease; D018392:Genomic Imprinting; D006801:Humans; D015994:Incidence; D007223:Infant; D007621:Karyotyping; D007938:Leukemia / Q000453:epidemiology / Q000235:genetics*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000453:epidemiology / Q000235:genetics; D015470:Leukemia, Myeloid, Acute / Q000453:epidemiology / Q000235:genetics; D008214:Lymphocytes / Q000166:cytology / Q000473:pathology; D008223:Lymphoma / Q000453:epidemiology / Q000235:genetics*; D008297:Male; D009190:Myelodysplastic Syndromes / Q000453:epidemiology / Q000235:genetics; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000453:epidemiology / Q000235:genetics; D012016:Reference Values